Anatara Lifesciences Ltd Stock

Equities

ANR

AU000000ANR0

Pharmaceuticals

Market Closed - Australian S.E. 11:13:41 2024-05-07 pm EDT 5-day change 1st Jan Change
0.04 AUD -13.04% Intraday chart for Anatara Lifesciences Ltd -16.67% +81.82%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2022 - Sales 2023 - Capitalization 3.36M 2.21M
Net income 2022 -2M -1.32M Net income 2023 -2M -1.32M EV / Sales 2022 -
Net cash position 2022 1.1M 726K Net cash position 2023 401K 264K EV / Sales 2023 -
P/E ratio 2022
-1.54 x
P/E ratio 2023
-1.35 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 63.89%
More Fundamentals * Assessed data
Dynamic Chart
1 day-13.04%
1 week-16.67%
Current month-16.67%
1 month+17.65%
3 months+66.67%
6 months+42.86%
Current year+81.82%
More quotes
1 week
0.04
Extreme 0.036
0.05
1 month
0.04
Extreme 0.036
0.05
Current year
0.02
Extreme 0.021
0.05
1 year
0.02
Extreme 0.021
0.05
3 years
0.02
Extreme 0.021
0.18
5 years
0.02
Extreme 0.021
0.45
10 years
0.02
Extreme 0.021
1.83
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 19-01-22
Chief Operating Officer - -
Corporate Officer/Principal - 21-12-05
Members of the board TitleAgeSince
Chief Executive Officer 63 19-01-22
Chief Operating Officer - -
Director/Board Member - -
More insiders
Date Price Change Volume
24-05-08 0.036 -21.74% 201,969
24-05-07 0.046 -4.17% 34,734
24-05-06 0.048 0.00% 338,192
24-05-03 0.048 0.00% 8,000
24-05-02 0.048 -2.04% 42,041

Delayed Quote Australian S.E., May 07, 2024 at 11:13 pm EDT

More quotes
Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW